Moreover, since BMI1 appears to be a crucial transcription factor regulated by Gli1, having shown that BMI1 inhibitors can control thyroid CSC self-renewal, BMI1 inhibitors should be further evaluated for their inhibitory activity on tumor growth and metastasis. The gene discussed is GLI1; the disease is neoplasm.